Photo: ReutersThe Ministry of Health is planning to fast-track the approval process for a Covid-19 vaccine, and won't rule out offering a supplier indemnity from any potential claims resulting from its use. The Ministry did not rule out offering indemnity to a vaccine supplier, as has happened previously. The Ministry said every potential supplier of the vaccine had the same conditions - indemnity "from any claims arising from the use of the vaccine". The vaccine types were: Inactivated virus; live attenuated virus; DNA-based vaccine; RNA-based vaccine; non-replicating viral vector; replicating viral vector; protein subunit; and virus-like particle. The government has dedicated $37m to the Covid-19 vaccine strategy, which includes support for local research and manufacturing, and support for international research.

Source: Otago Daily Times July 29, 2020 18:56 UTC